NEWS

News Articles

Georgia Research Alliance Trustees Name New President and CEO

September 27, 2023

Tim Denning, Ph.D. will succeed retiring Susan Shows in November The Trustees of the Georgia Research Alliance voted today to appoint Timothy Denning, Ph.D., vice president for research and economic development at Georgia State University, as the fifth president and CEO of GRA. He will take the reins from Susan Shows, who announced her retirement in a…

Read More

GRA President and CEO Susan Shows to Retire with 22-Year Legacy

September 27, 2023

Tenure marked by shaping all major aspects of the organization A driving factor in the development and success of the Georgia Research Alliance over a tenure that has spanned more than two decades, President and CEO Susan Shows today announced her retirement from the Alliance at the fall meeting of GRA’s Board of Trustees. Since…

Read More

Lucid Scientific Secures $7 Million Series A Financing Led by IAG Capital Partners

September 26, 2023

Maker of continuous real-time metabolic analysis systems experiences growing demand. Will build capacity for new product offerings, manufacturing, and global sales and marketing. September 26, 2023 05:42 PM Eastern Daylight Time ATLANTA–(BUSINESS WIRE)–Lucid Scientific, a life science instruments company that manufactures Resipher, announced the completion of a $7 million Series A financing led by IAG…

Read More

Saol Therapeutics Announces Completion of Enrollment in Both the Phase II COMPASS Osteoarthritis Knee Pain Trial and the Phase II RAISE Limb Spasticity Trial

September 19, 2023

SL-1002 is currently being developed for the treatment of chronic knee pain associated with osteoarthritis (COMPASS Trial) and mild to severe limb spasticity (RAISE Trial). Topline data for the COMPASS Osteoarthritis Knee Pain Trial will be available in the first quarter of 2024, with topline data from the RAISE Limb Spasticity Trial available shortly thereafter. …

Read More

ORPHAN Cures Act a “welcome and bipartisan fix” to the IRA’s negative impact on drug development 

September 19, 2023

September 18, 2023  | BIO Representatives John Joyce, M.D. (R-PA) and Wiley Nickel (D-NC) today introduced the Optimizing Research Progress Hope And New Cures (ORPHAN Cures Act). BIO President and CEO, Rachel King, made the following remarks:  “This legislation is a welcome and bipartisan fix to the Inflation Reduction Act’s (IRA) negative impact on the…

Read More

Danish manufacturing firm breaks ground in Peachtree City; 200 new jobs expected

September 13, 2023

By The Citizen-August 22, 2023 SP Meditec recently broke ground on a 120,000 square foot, state-of-the-art manufacturing facility that is expected to create 200 new jobs in Peachtree City. The plant, which will be located off Georgia State Route 74, is scheduled to begin operations in August 2024. Several factors played into SP Meditec’s selection…

Read More